AstraZeneca
AZN
#49
Rank
NZ$517.84 B
Marketcap
NZ$333.90
Share price
-0.22%
Change (1 day)
7.42%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2023 (TTM): NZ$3.28

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$11.96. In 2022 the company made an earnings per share (EPS) of NZ$1.90 an increase over its 2021 EPS that were of NZ$0.26.

EPS history for AstraZeneca from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$3.2872.61%
2022NZ$1.90631.03%
2021NZ$0.26-88.11%
2020NZ$2.19136.89%
2019NZ$0.92-39.41%
2018NZ$1.52-28.27%
2017NZ$2.12-14.37%
2016NZ$2.4824.11%
2015NZ$2.00127.55%
2014NZ$0.88-51.96%
2013NZ$1.83-58.95%
2012NZ$4.45-32.2%
2011NZ$6.5630.89%
2010NZ$5.017.9%
2009NZ$4.6523.57%
2008NZ$3.7612.3%
2007NZ$3.35-3.11%
2006NZ$3.4632.65%
2005NZ$2.61-94.03%
2004NZ$43.622651.98%
2003NZ$1.597.93%
2002NZ$1.471.32%
2001NZ$1.4512.88%
2000NZ$1.28120.59%
1999NZ$0.58-76.51%
1998NZ$2.481412.8%
1997NZ$0.16-88.43%
1996NZ$1.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.97 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.40-21.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.84-59.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.28 362.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.41-71.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$4.23-64.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.78-85.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.10-32.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.15-56.93%๐Ÿ‡ฌ๐Ÿ‡ง UK